No Evidence for Ceftobiprole-Induced Immune Hemolytic Anemia in Three Phase 3 Clinical Trials

PURPOSE: Drug-induced immune hemolytic anemia (DIIHA) is a rare but serious adverse event associated with a number of drugs, including second- and third-generation cephalosporins. A positive direct antiglobulin test (DAT) is a reliable finding in DIIHA, but positive results without evidence of hemol...

Descripción completa

Detalles Bibliográficos
Autores principales: Hamed, Kamal, Wiktorowicz, Tatiana, Assadi Gehr, Maziar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7502402/
https://www.ncbi.nlm.nih.gov/pubmed/32982335
http://dx.doi.org/10.2147/IDR.S268269

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7502402/
https://www.ncbi.nlm.nih.gov/pubmed/32982335
http://dx.doi.org/10.2147/IDR.S268269

Ejemplares similares